INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 415m ago
House PTR15m ago
SEC 13F14m ago
Robinhood Chain14m ago

Results

77,709 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
17
CB
Canton Barry10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
251.8K sh
Apr 9, 2026Apr 13, 2026
Page 1160 of 1943
← PrevNext →
traded Apr 9, 2026
+4d
SEC Form 4

Evidence

17
GW
Gassen WilliamDirector
OSCROscar Health, Inc.
Grant or award
A$21K
1,418 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

17
CJ
Cornelissen Bart JanSR. VICE PRESIDENT & CFO
XNCRXencor Inc
Open-market sale
SELL$43K
3,499 sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

17
MA
Moreno Mejia Luis AlbertoDirector
DOWDOW INC.
Grant or award
A—
5,127 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

17
CC
Chuang Shun-ChihChief Financial Officer
NCRANOCERA, INC.
Grant or award
A—
200.0K sh
Apr 13, 2026Apr 13, 2026
traded Apr 13, 2026
+0dSEC Form 4

Evidence

17
DL
Dial Debra L.Director
DOWDOW INC.
Grant or award
A—
5,127 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

17
PD
Plouffe DavidDirector
OSCROscar Health, Inc.
Grant or award
A$21K
1,461 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

17
DJ
Devard JerriDirector
DOWDOW INC.
Grant or award
A—
5,127 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

16
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$204K
15.7K sh
Apr 13, 2026Apr 13, 2026
traded Apr 13, 2026
+0dSEC Form 4

Evidence

16
PE
Pelish Henry E.Chief Scientific Officer
NUVLNuvalent, Inc.
Open-market sale · 10b5-1 plan
SELL$95K
900 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

16
LM
Liska MartinEVP / Chief Risk Officer
BCALCalifornia BanCorp \ CA
Other acquisition or disposition
J—
3,674 sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

16
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$238K
18.7K sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

16
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$234K
17.0K sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

16
PE
Pelish Henry E.Chief Scientific Officer
NUVLNuvalent, Inc.
Open-market sale · 10b5-1 plan
SELL$229K
2,193 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

16
PO
Pomel OlivierDirector, Chief Executive Officer
DDOGDatadog, Inc.
Open-market sale · 10b5-1 plan
SELL$627K
5,700 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

16
PO
Pomel OlivierDirector, Chief Executive Officer
DDOGDatadog, Inc.
Open-market sale · 10b5-1 plan
SELL$810K
7,295 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

16
HR
Howard Justyn RussellDirector, Executive Chair, 10% Owner
SPTSprout Social, Inc.
Open-market sale · 10b5-1 plan
SELL$201K
40.0K sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

16
PO
Pomel OlivierDirector, Chief Executive Officer
DDOGDatadog, Inc.
Open-market sale · 10b5-1 plan
SELL$307K
2,699 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

16
PO
Pomel OlivierDirector, Chief Executive Officer
DDOGDatadog, Inc.
Open-market sale · 10b5-1 plan
SELL$515K
4,606 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

16
PO
Pomel OlivierDirector, Chief Executive Officer
DDOGDatadog, Inc.
Open-market sale · 10b5-1 plan
SELL$464K
4,100 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

15
MR
Matt Peter RDirector, President and CEO
CMCCOMMERCIAL METALS Co
Tax withholding
F$307K
4,685 sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

15
VC
VandenAkker ColeChief Sales Officer
COOKTraeger, Inc.
Tax withholding
F$18K
602 sh
Apr 6, 2026Apr 13, 2026
traded Apr 6, 2026
+7dSEC Form 4

Evidence

14
TS
Trigg William ShaneDirector, Chief Executive Officer
APPFAPPFOLIO INC
Grant or award
A—
30.9K sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

13
RS
Rodgers StephanDirector
EHABEnhabit, Inc.
Grant or award
A$19K
1,340 sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

13
SV
Sankarlingam VelchamyPres. of Engineering & Product
ZMZoom Communications, Inc.
Option exercise
M—
20.8K sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

13
GG
Giterman Arthur G.Director, CEO and CFO
MYNDMynd.ai, Inc.
Tax withholding
F$42K
131.2K sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

13
CM
Chang MichelleChief Financial Officer
ZMZoom Communications, Inc.
Tax withholding · 10b5-1 plan
F$728K
8,743 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

13
PO
Pomel OlivierDirector, Chief Executive Officer
DDOGDatadog, Inc.
Open-market sale · 10b5-1 plan
SELL$58K
500 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

13
YD
Yohannes DanielDirector
DOWDOW INC.
Grant or award
A—
5,127 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

13
PO
Pomel OlivierDirector, Chief Executive Officer
DDOGDatadog, Inc.
Open-market sale · 10b5-1 plan
SELL$83K
700 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

13
FM
Fettig Jeff MDirector
DOWDOW INC.
Grant or award
A—
5,127 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

13
DK
Davis Richard KDirector
DOWDOW INC.
Grant or award
A—
5,127 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

13
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$47K
3,338 sh
Apr 13, 2026Apr 13, 2026
traded Apr 13, 2026
+0dSEC Form 4

Evidence

13
AR
Allen Samuel RDirector
DOWDOW INC.
Grant or award
A—
5,127 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

13
SY
Schlaeppi YvonneDirector
ALOTAstroNova, Inc.
Grant or award
A—
2,873 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

13
JW
Joseph WettenyChief Financial Officer
ZTSZoetis Inc.
Grant or award
A$35K
874 sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

13
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$5,392
400 sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

13
EM
Erlinger Joseph M.President, McDonald's USA
MCDMCDONALDS CORP
Option exercise · 10b5-1 plan
M$414K
2,626 sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

13
HC
Hinman Jacqueline C.Director
DOWDOW INC.
Grant or award
A—
5,127 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

13
SV
Sankarlingam VelchamyPres. of Engineering & Product
ZMZoom Communications, Inc.
Option exercise
M—
20.8K sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence